KALONA, Iowa, July 20, 2011 /PRNewswire/ -- CIVCO Medical Solutions is showcasing its RFSuite RFID tracking and verification system at AAPM booth #817. CIVCO is also hosting an RFSuite Symposium Monday, August 1st, from 12:30 – 2 p.m., in the Mackenzie Ballroom at the Fairmont Waterfront, Vancouver. The event will include lunch, pre-registration is required, and spots are still available. Click here to view the invitation and register. CIVCO's RFSuite Symposium will include several speakers experienced with RFID technology, including Todd Pawlicki, Ph.D., Director of Medical Physics and Clinical Operations at Moores Cancer Center in San Diego, California, and Alfredo Siochi, Ph.D., Assistant Professor and Director of Medical Physics Education in the Department of Radiation Oncology at the University of Iowa Hospital and Clinics in Iowa City, Iowa. Moores Cancer Center has been using CIVCO's RFSuite for nearly a year.
(Logo: http://photos.prnewswire.com/prnh/20110419/AQ85801LOGO)
"RFSuite and other innovative CIVCO solutions are providing the clinical community with today's tools needed to enhance safety and ensure the effective delivery of radiation therapy," said Geoffrey Dalbow, Chief Technology Officer for CIVCO. "We are collecting compelling clinical data on the use of RFID technologies to reduce errors and improve radiation oncology workflow at both Moores Cancer Center in San Diego, California, United States, and Hospital San Raffaele in Milan, Italy." CIVCO will also sponsor an RFID and Workflow Consortium at AAPM to learn more about the clinical benefits of RF technology.
The RFSuite system uses RFID technology to track patients, staff and equipment and to provide accessory and patient identity verification for treatment. "The use of RFID technology provides real time information about resource availability and pending tasks," said Siochi. "Schedule optimization could match resources to tasks and in our RFID simulation study, this reduced patient wait times by 30 minutes."
The RFSuite software, RFTrak™, provides a snapshot of where people and items are located in a facility in real time, improving workflow and reducing patient wait time. CIVCO's RFSeries™ line provides a broad array of RFID enabled products. "RFID technology is uniquely positioned to have a major impact in radiation oncology," said Pawlicki. "In addition to equipment and resource tracking, RFID will provide the real-time process data that can be used as the basis for comprehensive performance and safety programs. We look forward to working with CIVCO in developing their RFID technology as a key component of our data-driven improvement approaches such as Lean or Six Sigma."
About CIVCO
CIVCO Medical Solutions has over 30 years of experience and offers cutting-edge medical technology to a diverse group of medical professionals. The Multi-Modality Imaging (MMI) unit designs and manufactures accessories for use in diagnostic and therapeutic imaging and interventional procedures, with a strong focus on ultrasound. MMI's products range from infection control products including a wide range of ultrasound and CT covers to device guidance, positioning and electromagnetic needle tracking. CIVCO's Radiation Oncology division designs and manufactures products for radiation oncology treatment, including basic patient positioning equipment as well as high technology robotic motion management and advanced patient positioning for SBRT. CIVCO offers patients and clinicians the newest and best technology available to improve patient care.
Corporate information is available at www.CIVCO.com.
For Further Information, Please Contact:
Liz Etchells
Marketing Communications Specialist
Phone: 319-248-6551
Email: [email protected]
COPYRIGHT © 2011. CIVCO IS A REGISTERED TRADEMARK OF CIVCO MEDICAL SOLUTIONS. RFSUITE IS A TRADEMARK OF CIVCO. ALL OTHER TRADEMARKS ARE PROPERTY OF THEIR RESPECTIVE OWNERS. ALL PRODUCTS MAY NOT BE LICENSED IN ACCORDANCE WITH CANADIAN LAW. 2011C-0688.
SOURCE CIVCO Medical Solutions
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article